NBC4 anchor Jummy Olabanji recently sat down with SGF physicians Dr. Kate Devine and Dr. Nicole Doyle to learn more about their recent clinical study published in the Journal of American Medical Association (JAMA).  

NBC4 shares:  

Recent research suggests that a popular test that tens of thousands of women have done in the hopes of improving their chances of getting pregnant during IVF treatments is likely not worth the pain or expense for most patients. 

More than 750 women took part in the trial, undergoing an endometrial receptivity analysis, or ERA, test. During the test, doctors take a biopsy of the endometrial lining of a woman’s uterus and the sample is then analyzed to predict the best time for transferring an embryo. 

“We all very much hoped that this was going to be a test that would help women achieve their goal of family more efficiently, and, unfortunately, we did not find that. But it’s good news still in that we are able to help patients avoid cost, time, discomfort,” Devine said. 

“The data showed that the addition of an ERA did not increase the rate of live birth compared to a standard embryo transfer,” Dr. Nicole Doyle said. 

Doyle said families going through artificial reproductive technology want to try anything they can, but trials like this can help physicians guide patients to the right decisions. 

“Sometimes, you know, it’s not about adding on all these tests that are costly, invasive and time consuming. Sometimes it’s just a matter of trying again, you know, pick yourself up and trying again. So I just push them through the next transfer and after three, the majority of them are successful,” she said. 

See the full story on NBC 4’s website.

Learn more about ERA.